Soleus Capital Management, L.P.

Position in PRAX — Praxis Precision Medicines, Inc.

CIK 1802630 GREENWICH, CT

Position in PRAX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$59,430,916

-$47,058,356 QoQ

Shares Held

177,517

-46.3% QoQ

Ownership

0.636%

of shares outstanding

% of Portfolio

2.05%

of 13F equity value

Holder Rank

#36

of 306 holders

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Soleus Capital Management, L.P. holds $1,743,217,207 across 63 Biotechnology names. PRAX ranks #6 (3.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KRYS	Krystal Biotech, Inc.	939,254	$349,092,534
2	CELC	Celcuity Inc.	1,704,318	$178,305,749
3	TGTX	Tg Therapeutics, Inc.	2,927,895	$160,858,551
4	RIGL	Rigel Pharmaceuticals Inc	1,843,504	$72,117,876
5	VCEL	Vericel Corp	1,459,152	$64,917,672
6	PRAX	Praxis Precision Medicines, Inc. This page	177,517	$59,430,916
7	GERN	Geron Corp	42,808,659	$54,795,083
8	ERAS	Erasca, Inc.	2,700,000	$49,464,000

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$59,430,916	177,517	-46.3%	Shares	Sole	2026-08-11
2026-03-31	$106,489,272	330,517	-8.9%	Shares	Sole	2026-05-14
2025-12-31	$106,980,598	362,966	-57.8%	Shares	Sole	2026-02-12
2025-09-30	$45,535,798	859,166	-11.1%	Shares	Sole	2025-11-14
2025-06-30	$40,651,417	966,740	-15.2%	Shares	Sole	2025-08-15
2025-03-31	$43,161,953	1,139,740	+368.0%	Shares	Sole	2025-05-15
2024-12-31	$18,742,838	243,540	-6.1%	Shares	Sole	2025-02-14
2024-09-30	$14,925,760	259,398	-51.3%	Shares	Sole	2024-11-14
2024-06-30	$22,045,500	533,015	+1330.2%	Shares	Sole	2024-08-14
2024-03-31	$2,274,093	37,268	-96.8%	Shares	Sole	2024-05-15
2023-09-30	$1,966,500	1,150,000	-45.2%	Shares	Sole	2023-11-14
2023-06-30	$2,415,000	2,100,000	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.